Insider Trading activities of Karuna Therapeutics, Inc. (KRTX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Karuna Therapeutics, Inc. (KRTX) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Karuna Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Karuna Therapeutics, Inc. since 2005. The reporting company's ticker symbol is KRTX. The reporting company's CIK number is 1771917.
The total value of stock buying since 2005 is $18,523,589.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Karuna Therapeutics, Inc. (KRTX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-07 1,140,000 $18,292,139 0 $0 0 $0
2019-06 10,000 $231,450 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Karuna Therapeutics, Inc. insiders (KRTX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-07-02 Alexandria Venture Investments, Llc Buy 30,000 16.00 480,000
2019-07-02 Healy James (Director) Buy 700,000 16.00 11,200,000
2019-07-02 Chowrira Bharat M (Director) Buy 5,000 21.88 109,400
2019-07-02 Bybee Clinton (10% Owner) Buy 200,000 16.00 3,200,000
2019-07-02 Nelsen Robert (Director) Buy 200,000 16.00 3,200,000
2019-07-01 Chowrira Bharat M (Director) Buy 5,000 20.55 102,739
2019-06-28 Paul Steven M (President & CEO) Buy 10,000 23.14 231,450

Insider trading activities including stock purchases, stock sales, and option exercises of KRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Karuna Therapeutics, Inc. (symbol KRTX, CIK number 1771917) see the Securities and Exchange Commission (SEC) website.